The successful remission induction by sorafenib and long-term complete remission in a FLT3-ITD-positive patient with a refractory acute erythroid leukemia and abnormal cytogenetics. [electronic resource]
Producer: 20120201Description: e1-3 p. digitalISSN:- 1873-5835
- Abnormal Karyotype
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Cytogenetic Analysis
- Drug Resistance, Neoplasm -- drug effects
- Erythroid Cells -- pathology
- Female
- Gene Duplication
- Humans
- Leukemia, Erythroblastic, Acute -- drug therapy
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Pyridines -- therapeutic use
- Remission Induction
- Sorafenib
- Tandem Repeat Sequences -- genetics
- Time Factors
- Treatment Outcome
- fms-Like Tyrosine Kinase 3 -- genetics
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.